Cytoprotective and anticancer properties of coenzyme Q versus capsaicin

BioFactors

Volumn 18, Issue 1-4, 2003, Pages 195-205

  Galati, Giuseppe ^a   O'Brien, Peter J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anticancer; Capsaicin; Coenzyme Q; Hep G2 cells; Hepatocytes; Mitochondria

Indexed keywords

CAPSAICIN; CAPSAICIN DERIVATIVE; CARNITINE; CHLOROACETALDEHYDE; CREOSOL; CUMENE HYDROPEROXIDE; CYCLOSPORIN A; DIHYDROCAPSAICIN; METHYLCAPSAICIN; PHENOL DERIVATIVE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; ROTENONE; UBIQUINONE; UNCLASSIFIED DRUG; VANILLIN DERIVATIVE; VANILLYLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL DEATH; CELL PROTECTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; ELECTRON TRANSPORT; INHIBITION KINETICS; LIPID PEROXIDATION; LIVER CELL; MALE; MEMBRANE DAMAGE; MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0346158444     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520180222     Document Type: Conference Paper

References (25)

1. P. Mitchell, The vital protonmotive role of coenzyme Q, in: Biomedical and Clinical Aspects of Coenzyme Q, (vol. 6), K. Folkers, T. Yamagami and G.P. Littarru, eds, Elsevier Science Publishers, Amsterdam, 1991, pp. 3-10.
2. 10, Res Commun Chem Pathol Pharmacol 19 (1978), 485-490.
3. Y.S. Lee, D.H. Nam and J.A. Kim, Induction of apoptosis by capsaicin in A172 human glioblastoma cells, Cancer Lett 161 (2000), 121-130.
4. Y.J. Surh and S.S. Lee, Capsaicin, a double-edged sword: Toxicity, metabolism and chemopreventive potential, Life Sci 56 (1995), 1845-1855.
5. G.A. Cordell and O.E. Araujo, Capsaicin: identification, nomenclature, and pharmacotherapy, Ann Pharmacother 27 (1993), 330-336.
6. T. Chan, S. Teng, J.X. Wilson, G. Galati, S. Khan and P.J. O'Brien, Coenzyme Q cytoprotective mechanisms for mitochondrial complex 1 cytopathies involves NAD(P)H: Quinone Oxidoreductase 1(NQO1), Free Radic Res 36 (2002), 421-427.
7. T. Satoh, H. Miyoshi, K. Sakamoto and H. Iwamura, Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases, Biochim Biophys Acta 1273 (1996), 21-30.
8. P. Moldeus, J. Hogberg and S. Orrenius, Isolation and use of liver cells, Meth Enzymol 52 (1978), 60-71.
9. R.K. Eamus, R. Grunwald and J.J. Lemasters, Rhodamine 123 as a probe of transmembrane potential in isolated rat liver mitochondria: spectral and metabolic properties, Biochim Biophys Acta 850 (1986), 436-448.
10. C.P. LeBel, H. Ischiropoulos and S.C. Bondy, Evaluation of the probe 2′,7′-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress, Chem Res Toxicol 5 (1992), 227-231.
11. M.T. Smith, H. Thor, P. Hartizell and S. Orrenius, The measurement of lipid peroxidation in isolated hepatocytes, Biochem Pharmacol 31 (1982), 19-26.
12. J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna and J.B. Mitchell, Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing, Cancer Res 47 (1987), 936-942.
13. A.G. Siraki, J. Pourahmad, T.S. Chan, S. Khan and P.J. O'Brien, Endogenous and endobiotic induced reative oxygen species formation by isolated hepatocytes, Free Radic Biol Med 32 (2002), 2-10.
14. J.F. Turrens and A. Boveris, Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria, Biochem J 191 (1980), 421-427.
15. F. Vaillant, J.A. Larm, G.L. McMullen, E.J. Wolvetang and A. Lawen, Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators, J Bioenerg Biomembr 28 (1996), 531-540.
16. A. Arroyo, F. Navarro, C. Gomez-Diaz, F.L. Crane, F.J. Alcain, P. Navas and J.M. Villalba, Interactions between ascorbyl free radical and coenzyme Q at the plasma membrane, J Bioenerg Biomembr 32 (2000), 199-210.
17. V.E. Kagan, E.A. Serbinova, G.M. Koynova, S.A. Kitanova, V.A. Tyurin, T.S. Stoytchev, P.J. Quinn and L. Packer, Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes, Free Radic Biol Med 9 (1990), 117-126.
18. G. Lenaz, R. Fato, C. Castelluccio, M.L. Genova, C. Bovina, E. Estornell, V. Valls, F. Pallotti and C.G. Parenti, The function of coenzyme Q in mitochondria, Clin Invest 71 (1993), S66-S70.
19. C. Kim, F.L. Crane, W.P. Faulk and D.J. Morre, Purification and characterization of a doxorubicin-inhibited NADH-quinone (NADH-ferricyanide) reductase from rat liver plasma membranes, J Biol Chem 277 (2002), 16441-16447.
20. A. Lawen, R.D. Martinus, G.L. McMullen, P. Nagley, F. Vaillant, E.J. Wolvetang and A.W. Linnane, The universality of bioenergetic disease: The role of mitochondria and plasma membrane NADH oxidoreductase, Molec Aspects Med 15 (1994), S13-S27.
21. J.G. Pastorino, J.W. Snyder, A. Serroni, J.B. Hoek and J.L. Farber, Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting mitochondrial permeability transition, J Biol Chem 268 (1993), 13791-13798.
22. H. Miwa, J. Fujii, H. Kanno, N. Taniguchi and K. Aozasa, Pyruvate secreted by human lymphoid cell lines protects cells from hydrogen peroxide mediated cell death, Free Radic Res 33 (2000), 45-56.
23. T.C. Sarich, S.P. Adams, G. Petricca and J.M. Wright, Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor, J Pharmacol Exp Ther 289 (1999), 695-702.
24. P. Bernardi and G.F. Azzone, Cytochrome c as an electron shuttle between the outer and inner mitochondrial membranes, J Biol Chem 256 (1981), 7187-7192.
25. C.A. Reilly, W.J. Ehlhardt, D.A. Jackson, P. Kulanthaivel, A.E. Mutlib, R.J. Espina, D.E. Moody, D.J. Crouch and G.S. Yost, Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells, Chem Res Toxicol 16 (2003), 336-349.